After
completing preclinical testing, a company files an IND with the U.S.
Food and Drug Administration (FDA) to begin to test the drug in people.
The IND enables a sponsor to ship an unapproved drug in interstate
commerce. Clinical trials may proceed 30 days after filing unless
the FDA places a hold on the proposal.
